Crossmark

Performance evaluation of Bruker UMIC® microdilution panel and disc diffusion to determine cefiderocol susceptibility in Enterobacterales, Acinetobacter baumannii, Pseudomonas aeruginosa, Stenotrophomonas maltophilia, Achromobacter xylosoxidans and Burkolderia species

Crossref DOI link: https://doi.org/10.1007/s10096-024-04745-7

Published Online: 2024-01-19

Published Print: 2024-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bianco, Gabriele https://orcid.org/0000-0002-8180-5075
Boattini, Matteo

Comini, Sara

Gaibani, Paolo

Cavallo, Rossana

Costa, Cristina
Funding

Funding for this research was provided by:

International Society for Infectious Diseases (PE00000007, INF-ACT)
License Information

Text and Data Mining valid from 2024-01-19

Version of Record valid from 2024-01-19
More Information

Article History

Received: 7 November 2023

Accepted: 3 January 2024

First Online: 19 January 2024

Declarations

:

: Not applicable.

: Not applicable.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below